Development of a conjunctival contact–type drug delivery device for latanoprost using hyaluronic acid
Effective topical drug delivery is crucial for glaucoma treatment, necessitating more convenient methods to enhance patient compliance. This study evaluates the efficacy and safety of using freeze-dried hyaluronic acid (HA) as a carrier for a novel conjunctival-contact drug delivery system. We devel...
Saved in:
Main Authors: | Soomin Lee, Mi-Young Jung, Choul Yong Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2025.2459775 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the vascular structure of the conjunctiva in patients using spherical mini-scleral contact lenses utilizing OCT-A imaging
by: Fateme Alipour, et al.
Published: (2025-02-01) -
Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy
by: Ekaterina Pashkina, et al.
Published: (2025-01-01) -
Multiomics integration unravels genotype‐microbiome interactions shaping the conjunctival transcriptome
by: Qiaoxing Liang, et al.
Published: (2024-12-01) -
Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
by: Bacharach J, et al.
Published: (2025-01-01) -
A Prospective, Crossover, Randomized, Double-Blind Clinical Study Comparing the Effectiveness and Ocular Comfort of 0.1% Hyaluronic Acid and 0.3% Hyaluronic Acid in Patients With Dry Eye Disease
by: Kim SJ, et al.
Published: (2025-02-01)